| Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer (NCT04177810) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-11-16 |
| Improving Cancer On-treatment Symptom Management (NCT04589247) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-11-16 |
| Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer (NCT04331717) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-11-16 |
| TheraSphere® For Treatment of Metastases in Liver (NCT04517643) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-11-12 |
| A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors (NCT03914794) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-10-02 |
| Behavioral Weight Loss Program for Cancer Survivors in Maryland (NCT04534309) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-09-22 |
| Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM) (NCT04447651) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-09-17 |
| HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia (NCT04131413) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-09-14 |
| Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression (NCT04363164) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-08-19 |
| Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma (NCT04209686) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-07-31 |
| Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer (NCT04386746) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-07-29 |
| Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer (NCT04117087) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-05-28 |
| DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma (NCT04248569) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-04-20 |
| INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer (NCT04116073) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-04-09 |
| Proton Radiation Therapy Registry (NCT04376229) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-04-07 |
| EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression (NCT04266431) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-02-20 |
| Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM (NCT03961971) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-02-18 |
| Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy (NCT04171440) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-02-18 |
| BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations (NCT03914742) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-02-16 |
| Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures (NCT04232085) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-02-12 |
| Nivolumab in Biochemically Recurrent dMMR Prostate Cancer (NCT04019964) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-01-13 |
| AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery (NCT03965494) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-01-02 |
| Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas. (NCT03767582) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-12-12 |
| Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas (NCT03971734) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-12-06 |
| SBRT as a Vaccination for Metastatic Melanoma (NCT04042506) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-11-26 |
| Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy (NCT03619655) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-11-15 |
| Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors (NCT03576274) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-10-10 |
| Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma (NCT03918252) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-10-02 |
| CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab (NCT03638141) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-10-02 |
| Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer (NCT03800784) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-10-01 |
| Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete Remission (NCT03376477) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-09-23 |
| Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients (NCT04001413) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-09-17 |
| Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer (NCT03886493) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-08-28 |
| RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers (NCT04037358) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-08-09 |
| Tailored Home-Based Exercise Program for Multiple Chronic Conditions (NCT03874754) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-08-01 |
| Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG (NCT03973918) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-07-29 |
| Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN (NCT03878979) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-07-08 |
| Selective Transvenous Chemoembolization of Primary Pancreatic Tumors (NCT03865563) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-07-01 |
| Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer (NCT03768531) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-06-14 |
| A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor Malignancies (NCT03471286) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-06-06 |
| Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations (NCT03786796) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-06-03 |
| Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression (NCT03507608) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-05-10 |
| Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3) (NCT03792516) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-04-17 |
| Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors (NCT03875287) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-04-17 |
| Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer (NCT02405221) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-04-04 |
| Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer (NCT03793543) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-03-27 |
| Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma (NCT03707457) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-03-22 |
| Automated Method for Breast Cancer Detection (NCT03863522) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-03-07 |
| REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer (NCT03610711) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-03-06 |
| Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer (NCT03642067) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-02-12 |
| Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer (NCT03711058) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-01-17 |
| Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer (NCT02420977) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-12-06 |
| Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma (NCT03521830) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-11-27 |
| Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor (NCT03607890) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-11-16 |
| Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer (NCT03573648) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-11-13 |
| Muscadine Plus (MPX) In Men With Prostate Cancer (NCT03535675) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-10-30 |
| Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas (NCT02659800) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-10-30 |
| Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer (NCT03603002) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-10-16 |
| A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer (NCT03707444) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-10-01 |
| Resiliency in Older Adults Undergoing Bone Marrow Transplant (NCT04188678) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-09-28 |
| Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas (NCT03153410) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-09-27 |
| Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene Mutations (NCT03413995) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-09-10 |
| COMbination of Bipolar Androgen Therapy and Nivolumab (NCT03554317) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-09-05 |
| Skeletal Metastasis Registry (NCT05058014) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-08-16 |
| Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies (NCT03151057) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-07-31 |
| Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC (NCT03439735) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-07-20 |
| A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer (NCT03535727) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-06-21 |
| Cancer, Obesity/Overweight and Insomnia Study (NCT03542604) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-06-12 |
| Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer (NCT03307564) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-06-06 |
| Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer (NCT03523299) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-05-22 |
| A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas (NCT03593993) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-05-19 |
| Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC) (NCT03299946) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-05-14 |
| Radiosurgical Hypophysectomy for Bone Metasteses Pain (NCT03377517) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-05-08 |
| Terameprocol in Treating Patients With Recurrent High Grade Glioma (NCT02575794) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-05-03 |
| Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma (NCT03465592) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-05-01 |
| Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer (NCT03246074) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-04-03 |
| Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer (NCT03471650) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-03-29 |
| Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors (NCT03420521) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-03-09 |
| GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer (NCT03161379) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-02-02 |
| Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer (NCT03006302) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-01-31 |
| Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins (NCT02965755) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-01-26 |
| Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D) (NCT04098068) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-01-25 |
| Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer (NCT03190265) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-12-14 |
| Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer (NCT03237377) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-12-12 |
| Transcranial Direct Current Stimulation (tDCS) to Improve Fatigue and Cognitive Function (NCT03487601) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-12-12 |
| Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy (NCT03909464) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-11-29 |
| A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma (NCT03250273) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-11-06 |
| 5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme (NCT03291990) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-10-18 |
| MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple Myeloma (NCT03218163) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-09-27 |
| Assessing the Acceptability of the Use of a Mobile Health App Among Young Adult Female Survivors of Childhood Cancer (NCT03242200) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-09-26 |
| HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma (NCT03216499) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-09-14 |
| A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance (NCT03114865) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-09-05 |
| Study of Stereotactic Radiotherapy for Breast Cancer (NCT03043794) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-08-01 |
| Involving Family to Improve Communication in Breast Cancer Care (NCT03283553) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-07-20 |
| Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases (NCT03223922) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-07-19 |
| Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer (NCT03044613) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-07-11 |
| Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer (NCT02981524) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-05-26 |
| Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder (NCT02845323) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-05-16 |
| Pembrolizumab in Patients With Leptomeningeal Disease (NCT03091478) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-04-12 |
| Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma (NCT02212574) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-04-04 |